Top

Published in:

2015 | OriginalPaper | Chapter

15. Polymers in Cardiology

Authors : Katrin Sternberg, Raila Busch, Svea Petersen

Published in: Advanced Polymers in Medicine

Publisher: Springer International Publishing

Activate our intelligent search to find suitable subject content or patents.

search-config

AI-assisted search

Off

Abstract

Polymers have found widespread applications in cardiology, in particular in coronary vascular intervention as stent platforms, coating matrices for drug-eluting stents (DES) and drug-coated balloons (DCB) and for transcatheter valve therapy. Besides permanent polymers, biodegradable polymers came in focus of current research and development for medical applications, as they degrade once their function is fulfilled, which might efficiently reduce observed hypersensitivity reactions. After reviewing polymers used for cardiovascular applications, the book chapter deals with possible surface modification reactions of the polymers including the provision with a local drug delivery function and/or biofunctionalization in order to selectively control cell-implant interactions. These functionalizations can be furthermore designed to enhance bio- and hemo-compatibility, which is of special interest for cardiovascular implants and devices. A general discussion of bio- and hemo-compatibility of polymers for cardiovascular applications and corresponding evaluation methods is additionally given. With our own published data, we finally highlight exemplary polymer applications in cardiology as polymer-based biodegradable stent platforms, biodegradable polymeric coatings for DES and hydrogel-based coatings for DCB. Moreover, developed biofunctionalization strategies of polymers are discussed with regard to their application in cardiology.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

inform now

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 390 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Maschinenbau + Werkstoffe

Jetzt Wissensvorsprung sichern!

inform now

previous chapter Polymers in Wound Repair

next chapter Recent Advances in Hemocompatible Polymers for Biomedical Applications

Nair, L.S., Laurencin, C.T.: Biodegradable polymers as biomaterials. Prog. Polym. Sci. 32, 762–798 (2007). doi:10.1016/j.progpolymsci.2007.05.017

Tian, H., Tang, Z., Zhuang, X., et al.: Biodegradable synthetic polymers: preparation, functionalization and biomedical application. Prog. Polym. Sci. 37, 237–280 (2012). doi:10.1016/j.progpolymsci.2011.06.004

Venkatraman, S., Boey, F., Lao, L.L.: Implanted cardiovascular polymers: natural, synthetic and bio-inspired. Prog. Polym. Sci. 33, 853–874 (2008). doi:10.1016/j.progpolymsci.2008.07.001

Lendlein, A., Hofmann, D., Scharnagl, N.: Abbaubare polymere in der medizin. Nachr. Aus. Chem. 59, 117–120 (2011). doi:10.1515/NACHRCHEM.2011.59.2.117

Werner, C.: Nanomaterialien im Blut- und Gewebekontakt. Chem. Ing. Tech. 80, 1661–1670 (2008). doi:10.1002/cite.200800109

Luxenhofer, R., Groll, J.: Makromolekulare Chemie 2010. Nachr. Aus. Chem. 59, 324–334 (2011). doi:10.1515/NACHRCHEM.2011.59.3.324

Windecker, S., Meier, B.: Late coronary stent thrombosis. Circulation 116, 1952–1965 (2007). doi:10.1161/CIRCULATIONAHA.106.683995

Farb, A., Burke, A.P., Kolodgie, F.D., Virmani, R.: Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 108, 1701–1706 (2003). doi:10.1161/01.CIR.0000091115.05480.B0

Joner, M., Finn, A.V., Farb, A., et al.: Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J. Am. Coll. Cardiol. 48, 193–202 (2006). doi:10.1016/j.jacc.2006.03.042

10.

Lanzer, P., Sternberg, K., Schmitz, K.-P., et al.: Drug-eluting coronary stent very late thrombosis revisited. Herz 33, 334–342 (2008). doi:10.1007/s00059-008-3080-x

11.

Nebeker, J.R., Virmani, R., Bennett, C.L., et al.: Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J. Am. Coll. Cardiol. 47, 175–181 (2006). doi:10.1016/j.jacc.2005.07.071

12.

Virmani, R., Kolodgie, F.D., Farb, A.: Drug-eluting stents: are they really safe? Am. Heart. Hosp. J 2, 85–88 (2004). doi:10.1111/j.1541-9215.2004.03632.x

13.

Garg, S., Serruys, P.W.: Coronary stents: looking forward. J. Am. Coll. Cardiol. 56, S43–S78 (2010). doi:10.1016/j.jacc.2010.06.008

14.

Grabow, N., Martin, D.P., Schmitz, K.-P., Sternberg, K.: Absorbable polymer stent technologies for vascular regeneration. J. Chem. Technol. Biotechnol. 85, 744–751 (2010). doi:10.1002/jctb.2282

15.

Sun, D., Zheng, Y., Yin, T., et al.: Coronary drug-eluting stents: from design optimization to newer strategies. J. Biomed. Mater. Res. A 102, 1625–1640 (2014). doi:10.1002/jbm.a.34806

16.

Berg, M.C., Kolodziej, H., Cremers, B., et al.: Drug-coated angioplasty balloon catheters: coating compositions and methods. Adv. Eng. Mater. 14, B45–B50 (2012). doi:10.1002/adem.201180067

17.

Petersen, S., Minrath, I., Kaule, S., et al.: Development and in vitro characterization of photochemically crosslinked polyvinylpyrrolidone coatings for drug-coated balloons. Coat. 3, 253–267 (2013). doi:10.3390/coatings3040253

18.

Petersen, S., Kaule, S., Teske, M., et al.: Development and in vitro characterization of hyaluronic acid-based coatings for implant-associated local drug delivery systems. J. Chem. (2013). doi:10.1155/2013/587875

19.

Rippel, R.A., Ghanbari, H., Seifalian, A.M.: Tissue-engineered heart valve: future of cardiac surgery. World J. Surg. 36, 1581–1591 (2012). doi:10.1007/s00268-012-1535-y

20.

Rahmani, B., Burriesci, G., Mullen, M., Seifalian, A., Tzamtzis, S., Yap, J.: A new generation transcatheter heart valve with a novel nanocomposite material and fully retrievable design. J. Am. Coll. Cardiol. 60(17), B34–B34 (2012). doi: 10.1016/j.jacc.2012.08.126

21.

Heim, F., Durand, B., Chakfe, N.: Textile for heart valve prostheses: fabric long-term durability testing. J. Biomed. Mater. Res. B Appl. Biomater. 92, 68–77 (2010). doi:10.1002/jbm.b.31490

22.

Heim, F., Durand, B., Chafke, N.: Textile heart valve prosthesis: from fabric design criteria to early in-vivo performances. J. Heart Valve Dis. 22, 361–367 (2013)

23.

Rahmani, B., Tzamtzis, S., Ghanbari, H., et al.: Manufacturing and hydrodynamic assessment of a novel aortic valve made of a new nanocomposite polymer. J. Biomech. 45, 1205–1211 (2012). doi:10.1016/j.jbiomech.2012.01.046

24.

Parizek, M., Slepickova Kasalkova, N., Bacakova, L., et al.: Adhesion, growth, and maturation of vascular smooth muscle cells on low-density polyethylene grafted with bioactive substances. BioMed. Res. Int. 2013, e371430 (2013). doi:10.1155/2013/371430

25.

Ko, N.R., Sabbatier, G., Cunningham, A., et al.: Air-spun PLA nanofibers modified with reductively sheddable hydrophilic surfaces for vascular tissue engineering: synthesis and surface modification. Macromol. Rapid Commun. 35, 447–453 (2014). doi:10.1002/marc.201300609

26.

Theron, J.P., Knoetze, J.H., Sanderson, R.D., et al.: Modification, crosslinking and reactive electrospinning of a thermoplastic medical polyurethane for vascular graft applications. Acta Biomater. 6, 2434–2447 (2010). doi:10.1016/j.actbio.2010.01.013

27.

Hu, Z., Li, Z., Hu, L., et al.: The in vivo performance of small-caliber nanofibrous polyurethane vascular grafts. BMC Cardiovasc. Disord. 12, 115 (2012). doi:10.1186/1471-2261-12-115

28.

He, W., Hu, Z., Xu, A., et al.: The preparation and performance of a new polyurethane vascular prosthesis. Cell Biochem. Biophys. 66, 855–866 (2013). doi:10.1007/s12013-013-9528-5

29.

Han, J., Farah, S., Domb, A.J., Lelkes, P.I.: Electrospun rapamycin-eluting polyurethane fibers for vascular grafts. Pharm. Res. 30, 1735–1748 (2013). doi:10.1007/s11095-013-1016-5

30.

Pillai, C.K.S., Sharma, C.P.: Review paper: absorbable polymeric surgical sutures: chemistry, production, properties, biodegradability, and performance. J. Biomater. Appl. 25, 291–366 (2010). doi:10.1177/0885328210384890

31.

Hajiali, H., Shahgasempour, S., Naimi-Jamal, M.R., Peirovi, H.: Electrospun PGA/gelatin nanofibrous scaffolds and their potential application in vascular tissue engineering. Int. J. Nanomed. 6, 2133–2141 (2011). doi:10.2147/IJN.S24312

32.

Diban, N., Haimi, S., Bolhuis-Versteeg, L., et al.: Hollow fibers of poly(lactide-co-glycolide) and poly(ε-caprolactone) blends for vascular tissue engineering applications. Acta Biomater. 9, 6450–6458 (2013). doi:10.1016/j.actbio.2013.01.005

33.

Yi, F., Wu, H., Jia, G.-L.: Formulation and characterization of poly (d, l-lactide-co-glycolide) nanoparticle containing vascular endothelial growth factor for gene delivery. J. Clin. Pharm. Ther. 31, 43–48 (2006). doi:10.1111/j.1365-2710.2006.00702.x

34.

Yehia, S.A., Elshafeey, A.H., Elsayed, I.: A novel injectable in situ forming poly-dl-lactide and DL-lactide/glycolide implant containing lipospheres for controlled drug delivery. J. Liposome Res. 22, 128–138 (2012). doi:10.3109/08982104.2011.631141

35.

Amjadi, I., Rabiee, M., Hosseini, M.S., Mozafari, M.: Synthesis and characterization of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles as a sustained-release anticancer drug delivery system. Appl. Biochem. Biotechnol. 168, 1434–1447 (2012). doi:10.1007/s12010-012-9868-4

36.

Onuma, Y., Dudek, D., Thuesen, L., et al.: Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial. JACC Cardiovasc. Interv. 6, 999–1009 (2013). doi:10.1016/j.jcin.2013.05.017

37.

Bourantas, C.V., Papafaklis, M.I., Kotsia, A., et al.: Effect of the endothelial shear stress patterns on neointimal proliferation following drug-eluting bioresorbable vascular scaffold implantation: an optical coherence tomography study. JACC Cardiovasc. Interv. 7, 315–324 (2014). doi:10.1016/j.jcin.2013.05.034

38.

Bünger, C.M., Grabow, N., Kröger, C., et al.: Iliac anastomotic stenting with a sirolimus-eluting biodegradable poly-L-lactide stent: a preliminary study after 6 weeks. J. Endovasc. Ther. Off. J. Int. Soc. Endovasc. Spec. 13, 630–639 (2006). doi:10.1583/06-1899R.1

39.

Laaksovirta, S., Välimaa, T., Isotalo, T., et al.: Encrustation and strength retention properties of the self-expandable, biodegradable, self-reinforced L-lactide-glycolic acid co-polymer 80: 20 spiral urethral stent in vitro. J. Urol. 170, 468–471 (2003). doi:10.1097/01.ju.0000076389.88489.af

40.

Lumiaho, J., Heino, A., Kauppinen, T., et al.: Drainage and antireflux characteristics of a biodegradable self-reinforced, self-expanding X-ray-positive poly-L, D-lactide spiral partial ureteral stent: an experimental study. J. Endourol. Endourol. Soc. 21, 1559–1564 (2007). doi:10.1089/end.2005.0085

41.

Juuti, H., Kotsar, A., Mikkonen, J., et al.: The effect of pH on the degradation of biodegradable poly(l-lactide-co-glycolide) 80/20 urethral stent material in vitro. J. Endourol. Endourol. Soc. 26, 701–705 (2012). doi:10.1089/end.2011.0199

42.

Williams, S.F., Rizk, S., Martin, D.P.: Poly-4-hydroxybutyrate (P4HB): a new generation of resorbable medical devices for tissue repair and regeneration. Biomed. Tech. (Berl) 58, 439–452 (2013). doi:10.1515/bmt-2013-0009

43.

Van der Giessen, W.J., Lincoff, A.M., Schwartz, R.S., et al.: Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 94, 1690–1697 (1996)

44.

Celarek, A., Kraus, T., Tschegg, E.K., et al.: PHB, crystalline and amorphous magnesium alloys: promising candidates for bioresorbable osteosynthesis implants? Mater. Sci. Eng. C Mater. Biol. Appl. 32, 1503–1510 (2012). doi:10.1016/j.msec.2012.04.032

45.

Zonari, A., Novikoff, S., Electo, N.R.P., et al.: Endothelial differentiation of human stem cells seeded onto electrospun polyhydroxybutyrate/polyhydroxybutyrate-co-hydroxyvalerate fiber mesh. PLoS ONE 7, e35422 (2012). doi:10.1371/journal.pone.0035422

46.

Garg, S., Serruys, P.W.: Coronary stents: current status. J. Am. Coll. Cardiol. 56, S1–S42 (2010). doi:10.1016/j.jacc.2010.06.007

47.

Freier, T., Sternberg, K., Behrend, D., Schmitz, K-P.: Health issues of biopolymers: polyhydroxybutyrate. In: Doi, Y., Steinbüchel, A. (eds.) Biopolymers, vol. 10, pp. 247–280. Wiley-VCH, Weinheim (2003)

48.

Schmidt, C.E., Baier, J.M.: Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering. Biomaterials 21, 2215–2231 (2000)

49.

Hodde, J.: Naturally occurring scaffolds for soft tissue repair and regeneration. Tissue Eng. 8, 295–308 (2002). doi:10.1089/107632702753725058

50.

Heine, J., Schmiedl, A., Cebotari, S., et al.: Preclinical assessment of a tissue-engineered vasomotive human small-calibered vessel based on a decellularized xenogenic matrix: histological and functional characterization. Tissue Eng. Part A 17, 1253–1261 (2011). doi:10.1089/ten.TEA.2010.0375

51.

Tudorache, I., Cebotari, S., Sturz, G., et al.: Tissue engineering of heart valves: biomechanical and morphological properties of decellularized heart valves. J. Heart Valve Dis. 16, 567–573 (2007). discussion 574

52.

Tomizawa, Y.: Clinical benefits and risk analysis of topical hemostats: a review. J. Artif. Organs Off. J. Jpn. Soc. Artif. Organs 8, 137–142 (2005). doi:10.1007/s10047-005-0296-x

53.

Niiyama, H., Kuroyanagi, Y.: Development of novel wound dressing composed of hyaluronic acid and collagen sponge containing epidermal growth factor and vitamin C derivative. J. Artif. Organs Off. J. Jpn. Soc. Artif. Organs 17, 81–87 (2014). doi:10.1007/s10047-013-0737-x

54.

Wang, H.-L., Modarressi, M., Fu, J.-H.: Utilizing collagen membranes for guided tissue regeneration-based root coverage. Periodontol. 2000 59, 140–157 (2012). doi:10.1111/j.1600-0757.2011.00438.x

55.

Langer, R., Vacanti, J.P.: Tissue engineering. Science 260, 920–926 (1993)

56.

Dumitriu, S., Popa V.I.: Polymeric Biomaterials. CRC Press, Boca Raton (2013)

57.

Krenning, G., Moonen, J.-R.A.J., van Luyn, M.J.A., Harmsen, M.C.: Vascular smooth muscle cells for use in vascular tissue engineering obtained by endothelial-to-mesenchymal transdifferentiation (EnMT) on collagen matrices. Biomaterials 29, 3703–3711 (2008). doi:10.1016/j.biomaterials.2008.05.034

58.

Noishiki, Y., Ma, X.H., Yamane, Y., et al.: Succinylated collagen crosslinked by thermal treatment for coating vascular prostheses. Artif. Organs 22, 672–680 (1998)

59.

Marois, Y., Chakfé, N., Deng, X., et al.: Carbodiimide cross-linked gelatin: a new coating for porous polyester arterial prostheses. Biomaterials 16, 1131–1139 (1995)

60.

Li, D.X., Oh, Y.-K., Lim, S.-J., et al.: Novel gelatin microcapsule with bioavailability enhancement of ibuprofen using spray-drying technique. Int. J. Pharm. 355, 277–284 (2008). doi:10.1016/j.ijpharm.2007.12.020

61.

Manju, S., Muraleedharan, C.V., Rajeev, A., et al.: Evaluation of alginate dialdehyde cross-linked gelatin hydrogel as a biodegradable sealant for polyester vascular graft. J. Biomed. Mater. Res. B Appl. Biomater. 98, 139–149 (2011). doi:10.1002/jbm.b.31843

62.

Liu, Y., Chan-Park, M.B.: Hydrogel based on interpenetrating polymer networks of dextran and gelatin for vascular tissue engineering. Biomaterials 30, 196–207 (2009). doi:10.1016/j.biomaterials.2008.09.041

63.

Bos, G.W., Scharenborg, N.M., Poot, A.A., et al.: Proliferation of endothelial cells on surface-immobilized albumin-heparin conjugate loaded with basic fibroblast growth factor. J. Biomed. Mater. Res. 44, 330–340 (1999). doi:10.1002/(SICI)1097-4636(19990305)44:3<330:AID-JBM12>3.0.CO;2-O

64.

Scholz, B., Kinzelmann, C., Benz, K., et al.: Suppression of adverse angiogenesis in an albumin-based hydrogel for articular cartilage and intervertebral disc regeneration. Eur. Cell Mater. 20, 24–36 (2010). discussion 36–37

65.

McCargar, R., Jenson, K., Dayton, A., et al.: Preparation of dissolvable albumin stents for vascular anastomosis with a 1.9 µm laser and in vitro mechanical strength assessments. Lasers Surg. Med. 44, 330–338 (2012). doi:10.1002/lsm.22015

66.

Fathi, A., Mithieux, S.M., Wei, H., et al.: Elastin based cell-laden injectable hydrogels with tunable gelation, mechanical and biodegradation properties. Biomaterials 35, 5425–5435 (2014). doi:10.1016/j.biomaterials.2014.03.026

67.

Kim, W., Chaikof, E.L.: Recombinant elastin-mimetic biomaterials: emerging applications in medicine. Adv. Drug Deliv. Rev. 62, 1468–1478 (2010). doi:10.1016/j.addr.2010.04.007

68.

Kolakovic, R., Peltonen, L., Laukkanen, A., et al.: Nanofibrillar cellulose films for controlled drug delivery. Eur. J. Pharm. Biopharm. Off. J. Arbeitsgemeinschaft Für Pharm Verfahrenstechnik EV 82, 308–315 (2012). doi:10.1016/j.ejpb.2012.06.011

69.

Santander-Ortega, M.J., Stauner, T., Loretz, B., et al.: Nanoparticles made from novel starch derivatives for transdermal drug delivery. J. Control. Release Off. J. Control Release Soc. 141, 85–92 (2010). doi:10.1016/j.jconrel.2009.08.012

70.

Gandhi, J.K., Opara, E.C., Brey, E.M.: Alginate-based strategies for therapeutic vascularization. Ther. Deliv. 4, 327–341 (2013). doi:10.4155/tde.12.163

71.

Dubuis, C., May, L., Alonso, F., et al.: Atorvastatin-loaded hydrogel affects the smooth muscle cells of human veins. J. Pharmacol. Exp. Ther. 347, 574–581 (2013). doi:10.1124/jpet.113.208769

72.

Fan, W., Yan, W., Xu, Z., Ni, H.: Erythrocytes load of low molecular weight chitosan nanoparticles as a potential vascular drug delivery system. Colloids. Surf. B Biointerfaces 95, 258–265 (2012). doi:10.1016/j.colsurfb.2012.03.006

73.

Bidarra, S.J., Barrias, C.C., Fonseca, K.B., et al.: Injectable in situ crosslinkable RGD-modified alginate matrix for endothelial cells delivery. Biomaterials 32, 7897–7904 (2011). doi:10.1016/j.biomaterials.2011.07.013

74.

Zhu, C., Fan, D., Wang, Y.: Human-like collagen/hyaluronic acid 3D scaffolds for vascular tissue engineering. Mater. Sci. Eng. C Mater. Biol. Appl. 34, 393–401 (2014). doi:10.1016/j.msec.2013.09.044

75.

Du, F., Wang, H., Zhao, W., et al.: Gradient nanofibrous chitosan/poly ε-caprolactone scaffolds as extracellular microenvironments for vascular tissue engineering. Biomaterials 33, 762–770 (2012). doi:10.1016/j.biomaterials.2011.10.037

76.

Shen, L., Wu, Y., Zhang, F., et al.: Assessment of an asymmetrical coating stent with sirolimus released from ablumial matrix in porcine model. Clin. Res. Cardiol. Off. J. Ger. Card. Soc. 101, 917–927 (2012). doi:10.1007/s00392-012-0476-7

77.

Ye, X., Wang, H., Zhou, J., et al.: The effect of heparin-VEGF multilayer on the biocompatibility of decellularized aortic valve with platelet and endothelial progenitor cells. PLoS ONE 8, e54622 (2013). doi:10.1371/journal.pone.0054622

78.

Bae, I.-H., Park, I.-K., Park, D.S., et al.: Thromboresistant and endothelialization effects of dopamine-mediated heparin coating on a stent material surface. J. Mater. Sci. Mater. Med. 23, 1259–1269 (2012). doi:10.1007/s10856-012-4587-5

79.

Mellon, S.J., Liddle, A.D., Pandit, H.: Hip replacement: landmark surgery in modern medical history. Maturitas 75, 221–226 (2013). doi:10.1016/j.maturitas.2013.04.011

80.

Galdbart, J.O., Branger, C., Andreassian, B., et al.: Elution of six antibiotics bonded to polyethylene vascular grafts sealed with three proteins. J. Surg. Res. 66, 174–178 (1996). doi:10.1006/jsre.1996.0391

81.

Tajirian, A.L., Goldberg, D.J.: A review of sutures and other skin closure materials. J. Cosmet. Laser Ther. Off. Publ. Eur. Soc. Laser Dermatol. 12, 296–302 (2010). doi:10.3109/14764172.2010.538413

82.

Ulrich, D., Edwards, S.L., Su, K., et al.: Human endometrial mesenchymal stem cells modulate the tissue response and mechanical behavior of polyamide mesh implants for pelvic organ prolapse repair. Tissue Eng. Part A 20, 785–798 (2014). doi:10.1089/ten.TEA.2013.0170

83.

Desai, M., Seifalian, A.M., Hamilton, G.: Role of prosthetic conduits in coronary artery bypass grafting. Eur. J. Cardio-Thorac. Surg. Off. J. Eur. Assoc. Cardio-Thorac Surg. 40, 394–398 (2011). doi:10.1016/j.ejcts.2010.11.050

84.

Farrar, D.J.: Development of a prosthetic coronary artery bypass graft. Heart Surg. Forum. 3, 36–40 (2000)

85.

Lendlein, A.: Polymere als implantatwerkstoffe. Chem. Unserer Zeit 33, 279–295 (1999). doi:10.1002/ciuz.19990330505

86.

Naoum, J.J., Arbid, E.J.: Bypass surgery in limb salvage: polytetrafluoroethylene prosthetic bypass. Methodist DeBakey Cardiovasc. J. 8, 43–46 (2012)

87.

Wise, S.G., Waterhouse, A., Kondyurin, A., et al.: Plasma-based biofunctionalization of vascular implants. Nanomed 7, 1907–1916 (2012). doi:10.2217/nnm.12.161

88.

Fujimoto, K., Honda, K., Wada, Y.R., et al.: Four-year experience with a silicone refractive multifocal intraocular lens. J. Cataract Refract. Surg. 36, 1330–1335 (2010). doi:10.1016/j.jcrs.2010.02.021

89.

Findl, O., Buehl, W., Bauer, P., Sycha, T.: Interventions for preventing posterior capsule opacification. Cochrane Database Syst. Rev. (2), CD003738 (2010). doi:10.1002/14651858.CD003738.pub3. Review. PMID: 20166069

90.

Dieterich, M., Faridi, A.: Biological matrices and synthetic meshes used in implant-based breast reconstruction—a review of products available in Germany. Geburtshilfe Frauenheilkd 73, 1100–1106 (2013). doi:10.1055/s-0033-1350930

91.

Bohl, A., Rohm, H.W., Ceschi, P., et al.: Development of a specially tailored local drug delivery system for the prevention of fibrosis after insertion of cochlear implants into the inner ear. J. Mater. Sci. Mater. Med. 23, 2151–2162 (2012). doi:10.1007/s10856-012-4698-z

92.

Sisson, A.L., Schroeter, M., Lendlein, A.: Polyesters. In: Lendlein, A., Sisson, A. (eds.) Handbook Biodegradable Polymers, pp. 1–21. Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim (2011)

93.

Polak, M.B., Valamanesh, F., Felt, O., et al.: Controlled delivery of 5-chlorouracil using poly(ortho esters) in filtering surgery for glaucoma. Invest. Ophthalmol. Vis. Sci. 49, 2993–3003 (2008). doi:10.1167/iovs.07-0919

94.

Rothstein, S.N., Federspiel, W.J., Little, S.R.: A unified mathematical model for the prediction of controlled release from surface and bulk eroding polymer matrices. Biomaterials 30, 1657–1664 (2009). doi:10.1016/j.biomaterials.2008.12.002

95.

Palamoor, M., Jablonski, M.M.: Synthesis, characterization and in vitro studies of celecoxib-loaded poly(ortho ester) nanoparticles targeted for intraocular drug delivery. Colloids Surf. B Biointerfaces 112, 474–482 (2013). doi:10.1016/j.colsurfb.2013.07.039

96.

Iqbal, J., Gunn, J., Serruys, P.W.: Coronary stents: historical development, current status and future directions. Br. Med. Bull. 106, 193–211 (2013). doi:10.1093/bmb/ldt009

97.

Tamai, H., Igaki, K., Kyo, E., et al.: Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans. Circulation 102, 399–404 (2000)

98.

Patel, M.J., Patel, S.S., Patel, N.S., Patel, N.M.: Current status and future prospects of drug eluting stents for restenosis. Acta Pharm. Zagreb Croat 62, 473–496 (2012). doi:10.2478/v10007-012-0036-8

99.

Udipi, K., Chen, M., Cheng, P., et al.: Development of a novel biocompatible polymer system for extended drug release in a next-generation drug-eluting stent. J. Biomed. Mater. Res. A 85A, 1064–1071 (2008). doi:10.1002/jbm.a.31664

100.

Scheller, B., Speck, U., Romeike, B., et al.: Contrast media as carriers for local drug delivery successful inhibition of neointimal proliferation in the porcine coronary stent model. Eur. Heart J. 24, 1462–1467 (2003). doi:10.1016/S0195-668X(03)00317-8

101.

Speck, U., Scheller, B., Abramjuk, C., et al.: Neointima inhibition: comparison of effectiveness of non–stent-based local drug delivery and a drug-eluting stent in porcine coronary arteries1. Radiology 240, 411–418 (2006). doi:10.1148/radiol.2402051248

102.

Scheller, B., Hehrlein, C., Bocksch, W., et al.: Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N. Engl. J. Med. 355, 2113–2124 (2006). doi:10.1056/NEJMoa061254

103.

Tepe, G., Zeller, T., Albrecht, T., et al.: Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N. Engl. J. Med. 358, 689–699 (2008). doi:10.1056/NEJMoa0706356

104.

Werk, M., Langner, S., Reinkensmeier, B., et al.: Inhibition of restenosis in femoropopliteal arteries paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation 118, 1358–1365 (2008). doi:10.1161/CIRCULATIONAHA.107.735985

105.

Loh, J.P., Waksman, R.: Paclitaxel drug-coated balloons: a review of current status and emerging applications in native coronary artery de novo lesions. JACC Cardiovasc. Interv. 5, 1001–1012 (2012). doi:10.1016/j.jcin.2012.08.005

106.

Joner, M., Byrne, R.A., Lapointe, J.-M., et al.: Comparative assessment of drug-eluting balloons in an advanced porcine model of coronary restenosis. Thromb. Haemost. 105, 864–872 (2011). doi:10.1160/TH10-11-0698

107.

Cremers, B., Clever, Y., Schaffner, S., et al.: Treatment of coronary in-stent restenosis with a novel paclitaxel urea coated balloon. Minerva Cardioangiol. 58, 583–588 (2010)

108.

Arbeitsgruppe Interventionelle Kardiologie (AGIK) der Deutschen Gesellschaft für Kardiologie (DGK), Scheller, B., Levenson, B., et al.: Medikamente freisetzende Koronarstents und mit Medikamenten beschichtete Ballonkatheter: Positionspapier der DGK 2011. Kardiologe 5, 411–435 (2011). doi:10.1007/s12181-011-0375-6

109.

Ratner, B.D., Hoffman, A.S., Schoen, F.J., et al.: Biomaterials Science: An Introduction to Materials in Medicine, 1st edn. Academic Press, San Diego (1997)

110.

Acharya, G., Park, K.: Mechanisms of controlled drug release from drug-eluting stents. Adv. Drug Deliv. Rev. 58, 387–401 (2006). doi:10.1016/j.addr.2006.01.016

111.

Sternberg, K., Petersen, S., Grabow, N., et al.: Implant-associated local drug delivery systems based on biodegradable polymers: customized designs for different medical applications. Biomed. Tech. (Berl) 58, 417–427 (2013). doi:10.1515/bmt-2012-0049

112.

Uhrich, K.E., Cannizzaro, S.M., Langer, R.S., Shakesheff, K.M.: Polymeric systems for controlled drug release. Chem. Rev. 99, 3181–3198 (1999)

113.

Qiu, Y., Park, K.: Environment-sensitive hydrogels for drug delivery. Adv. Drug Deliv. Rev. 53, 321–339 (2001). doi:10.1016/S0169-409X(01)00203-4

114.

Siegel, R.A., Firestone, B.A.: pH-dependent equilibrium swelling properties of hydrophobic polyelectrolyte copolymer gels. Macromolecules 21, 3254–3259 (1988). doi:10.1021/ma00189a021

115.

Tanaka, T.: Collapse of gels and the critical endpoint. Phys. Rev. Lett. 40, 820–823 (1978). doi:10.1103/PhysRevLett.40.820

116.

Hoffman, A.S.: Applications of thermally reversible polymers and hydrogels in therapeutics and diagnostics. J. Control. Release 6, 297–305 (1987). doi:10.1016/0168-3659(87)90083-6

117.

Bae, Y.H., Okano, T., Hsu, R., Kim, S.W.: Thermo-sensitive polymers as on-off switches for drug release. Makromol. Chem. Rapid Commun. 8, 481–485 (1987). doi:10.1002/marc.1987.030081002

118.

Aoki, T., Kawashima, M., Katono, H., et al.: Temperature-responsive interpenetrating polymer networks constructed with poly(acrylic acid) and poly(N, N-dimethylacrylamide). Macromolecules 27, 947–952 (1994). doi:10.1021/ma00082a010

119.

Zhang, R., Bowyer, A., Eisenthal, R., Hubble, J.: A smart membrane based on an antigen-responsive hydrogel. Biotechnol. Bioeng. 97, 976–984 (2007). doi:10.1002/bit.21255

120.

Tang, M., Zhang, R., Bowyer, A., et al.: A reversible hydrogel membrane for controlling the delivery of macromolecules. Biotechnol. Bioeng. 82, 47–53 (2003). doi:10.1002/bit.10539

121.

Lu, B., Xie, J., Lu, C., et al.: Oriented immobilization of Fab’ fragments on silica surfaces. Anal. Chem. 67, 83–87 (1995). doi:10.1021/ac00097a014

122.

Lu, Z.R., Kopecková, P., Kopecek, J.: Polymerizable Fab’ antibody fragments for targeting of anticancer drugs. Nat. Biotechnol. 17, 1101–1104 (1999). doi:10.1038/15085

123.

Miyata, T., Asami, N., Uragami, T.: A reversibly antigen-responsive hydrogel. Nature 399, 766–769 (1999). doi:10.1038/21619

124.

Miyata, T., Asami, N., Uragami, T.: Structural design of stimuli-responsive bioconjugated hydrogels that respond to a target antigen. J. Polym. Sci. Part B Polym. Phys. 47, 2144–2157 (2009). doi:10.1002/polb.21812

125.

Miyata, T., Asami, N., Okita, Y., Uragami, T.: Controlled permeation of model drugs through a bioconjugated membrane with antigen–antibody complexes as reversible crosslinks. Polym. J. 42, 834–837 (2010). doi:10.1038/pj.2010.76

126.

Miyata, T., Uragami, T., Nakamae, K.: Biomolecule-sensitive hydrogels. Adv. Drug Deliv. Rev. 54, 79–98 (2002). doi:10.1016/S0169-409X(01)00241-1

127.

Minrath, I., Arbeiter, D., Schmitz, K-P., et al.: In vitro characterization of polyacrylamide hydrogels for application as implant coating for stimulus-responsive local drug delivery. Polym. Adv. Technol. n/a–n/a (2014). doi:10.1002/pat.3294

128.

Hanawa, T.: Materials for metallic stents. J. Artif. Organs Off. J. Jpn. Soc. Artif. Organs 12, 73–79 (2009). doi:10.1007/s10047-008-0456-x

129.

Kukreja, N., Onuma, Y., Daemen, J., Serruys, P.W.: The future of drug-eluting stents. Pharmacol. Res. Off J. Ital. Pharmacol. Soc. 57, 171–180 (2008). doi:10.1016/j.phrs.2008.01.012

130.

Grube, E., Gerckens, U., Müller, R., Büllesfeld, L.: Drug eluting stents: initial experiences. Z Für Kardiologie 91(Suppl 3), 44–48 (2002)

131.

Sternberg, K., Kramer, S., Nischan, C., et al.: In vitro study of drug-eluting stent coatings based on poly(l-lactide) incorporating cyclosporine A—drug release, polymer degradation and mechanical integrity. J. Mater. Sci. Mater. Med. 18, 1423–1432 (2007). doi:10.1007/s10856-007-0148-8

132.

Ge, J., Qian, J., Wang, X., et al.: Effectiveness and safety of the sirolimus-eluting stents coated with bioabsorbable polymer coating in human coronary arteries. Catheter Cardiovasc. Interv. Off J. Soc. Card. Angiogr. Interv. 69, 198–202 (2007). doi:10.1002/ccd.20926

133.

Serruys, P.W., Ong, A.T.L., Piek, J.J., et al.: A randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trial. EuroIntervention J. Eur. Collab. Work Group Interv. Cardiol. Eur. Soc. Cardiol. 1, 58–65 (2005)

134.

Pan, C.J., Tang, J.J., Weng, Y.J., et al.: Preparation and characterization of rapamycin-loaded PLGA coating stent. J. Mater. Sci. Mater. Med. 18, 2193–2198 (2007). doi:10.1007/s10856-007-3075-9

135.

Goddard, J.M., Hotchkiss, J.H.: Polymer surface modification for the attachment of bioactive compounds. Prog. Polym. Sci. 32, 698–725 (2007). doi:10.1016/j.progpolymsci.2007.04.002

136.

Kong, J.-S., Lee, D.-J., Kim, H.-D.: Surface modification of low-density polyethylene (LDPE) film and improvement of adhesion between evaporated copper metal film and LDPE. J. Appl. Polym. Sci. 82, 1677–1690 (2001). doi:10.1002/app.2008

137.

Bag, D.S., Kumar, V.P., Maiti, S.: Chemical modification of LDPE film. J. Appl. Polym. Sci. 71, 1041–1048 (1999). doi:10.1002/(SICI)1097-4628(19990214)71:7<1041:AID-APP1>3.0.CO;2-R

138.

Tao, G., Gong, A., Lu, J., et al.: Surface functionalized polypropylene: synthesis, characterization, and adhesion properties. Macromolecules 34, 7672–7679 (2001). doi:10.1021/ma010941b

139.

Sheng IS, E.: Effects of the chromic acid etching on propylene polymer surfaces. J. Adhes. Sci. Technol. 9, 47–60 (1995). doi:10.1163/156856195X00284

140.

Brown, L., Koerner, T., Horton, J.H., Oleschuk, R.D.: Fabrication and characterization of poly(methylmethacrylate) microfluidic devices bonded using surface modifications and solvents. Lab. Chip 6, 66–73 (2006). doi:10.1039/b512179e

141.

Wulf, K., Teske, M., Löbler, M., et al.: Surface functionalization of poly(ε-caprolactone) improves its biocompatibility as scaffold material for bioartificial vessel prostheses. J. Biomed. Mater. Res. B Appl. Biomater. 98B, 89–100 (2011). doi:10.1002/jbm.b.31836

142.

Fixe, F., Dufva, M., Telleman. P., Christensen, C.B.V.: Functionalization of poly(methyl methacrylate) (PMMA) as a substrate for DNA microarrays. Nucleic Acids Res. 32:e9 (2004). doi:10.1093/nar/gng157

143.

Henry, A.C., Tutt, T.J., Galloway, M., et al.: Surface modification of poly(methyl methacrylate) used in the fabrication of microanalytical devices. Anal. Chem. 72, 5331–5337 (2000). doi:10.1021/ac000685l

144.

Zhu, Y., Gao, C., He, T., Shen, J.: Endothelium regeneration on luminal surface of polyurethane vascular scaffold modified with diamine and covalently grafted with gelatin. Biomaterials 25, 423–430 (2004)

145.

Zhu, Y., Gao, C., Liu, Y., Shen, J.: Endothelial cell functions in vitro cultured on poly(L-lactic acid) membranes modified with different methods. J. Biomed. Mater. Res. A 69, 436–443 (2004). doi:10.1002/jbm.a.30007

146.

Petersen, S., Strohbach, A., Busch, R., et al.: Site-selective immobilization of anti-CD34 antibodies to poly(L-lactide) for endovascular implant surfaces. J. Biomed. Mater. Res. B Appl. Biomater. 102(2), 345–355 (2013)

147.

Croll, T.I., O’Connor, A.J., Stevens, G.W., Cooper-White, J.J.: Controllable surface modification of poly(lactic-co-glycolic acid) (PLGA) by hydrolysis or aminolysis I: physical, chemical, and theoretical aspects. Biomacromolecules 5, 463–473 (2004). doi:10.1021/bm0343040

148.

Desai, S.M., Singh, R.P.: Surface modification of polyethylene. In: Albertsson, A.-C. (ed.) Long Term Properties of Polyolefins, pp. 231–294. Springer, Berlin (2004)

149.

Oyane, A., Uchida, M., Yokoyama, Y., et al.: Simple surface modification of poly(epsilon-caprolactone) to induce its apatite-forming ability. J. Biomed. Mater. Res. A 75, 138–145 (2005). doi:10.1002/jbm.a.30397

150.

Kim, Y.J., Kang, I.K., Huh, M.W., Yoon, S.C.: Surface characterization and in vitro blood compatibility of poly(ethylene terephthalate) immobilized with insulin and/or heparin using plasma glow discharge. Biomaterials 21, 121–130 (2000)

151.

Aouinti, M., Bertrand, P., Poncin-Epaillard, F.: Characterization of polypropylene surface treated in a CO₂ plasma. Plasmas Polym. 8, 225–236 (2003). doi:10.1023/A:1026392525543

152.

Wang, M.-J., Chang, Y.-I., Poncin-Epaillard, F.: Acid and basic functionalities of nitrogen and carbon dioxide plasma-treated polystyrene. Surf. Interface Anal. 37, 348–355 (2005). doi:10.1002/sia.2029

153.

Crombez, M., Chevallier, P., Gaudreault, R.C., et al.: Improving arterial prosthesis neo-endothelialization: application of a proactive VEGF construct onto PTFE surfaces. Biomaterials 26, 7402–7409 (2005). doi:10.1016/j.biomaterials.2005.05.051

154.

Morent, R., De Geyter, N., Desmet, T., et al.: Plasma surface modification of biodegradable polymers: a review. Plasma Process. Polym. 8, 171–190 (2011). doi:10.1002/ppap.201000153

155.

Whitesides, G.M., Laibinis, P.E.: Wet chemical approaches to the characterization of organic surfaces: self-assembled monolayers, wetting, and the physical-organic chemistry of the solid-liquid interface. Langmuir 6, 87–96 (1990). doi:10.1021/la00091a013

156.

Petersen, S., Wulf, K., Schünemann, S., Teske, M., Schmitz, K.-P., Sternberg, K.: Biofunctionalization of polymer implant surfaces: from drug delivery to stable surface functionality. Biomed. Eng. Biomed. Tech. Biomed. Tech. (Berl) (2013). pii: /j/bmte.2013.58.issue-s1-C/bmt-2013-4052/bmt-2013-4052.xml. doi:10.1515/bmt-2013-4052

157.

Bahulekar, R., Ayyangar, N.R., Ponrathnam, S.: Polyethyleneimine in immobilization of biocatalysts. Enzym. Microb. Technol. 13, 858–868 (1991)

158.

Dykes, G.M.: Dendrimers: a review of their appeal and applications. J. Chem. Technol. Biotechnol. 76, 903–918 (2001). doi:10.1002/jctb.464

159.

Holmberg, K., Tiberg, F., Malmsten, M., Brink, C.: Grafting with hydrophilic polymer chains to prepare protein-resistant surfaces. Colloids Surf. Physicochem. Eng. Asp. 123–124, 297–306 (1997). doi:10.1016/S0927-7757(96)03810-1

160.

Hermanson, G.T.: Bioconjugate Techniques. Academic Press, Waltham (2010)

161.

Serruys, P.W., Emanuelsson, H., van der Giessen, W., et al.: Heparin-coated Palmaz-Schatz stents in human coronary arteries. Early outcome of the Benestent-II Pilot Study. Circulation 93, 412–422 (1996)

162.

Serruys, P.W., van Hout, B., Bonnier, H., et al.: Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II). Lancet 352, 673–681 (1998)

163.

Vrolix, M.C.M., Legrand, V.M., Reiber, J.H.C., et al.: Heparin-coated Wiktor stents in human coronary arteries (MENTOR Trial). Am. J. Cardiol. 86, 385–389 (2000)

164.

Wöhrle, J., Al-Khayer, E., Grötzinger, U., et al.: Comparison of the heparin coated vs the uncoated Jostent–no influence on restenosis or clinical outcome. Eur. Heart J. 22, 1808–1816 (2001). doi:10.1053/euhj.2001.2608

165.

Holmes, D.R., Camrud, A.R., Jorgenson, M.A., et al.: Polymeric stenting in the porcine coronary artery model: differential outcome of exogenous fibrin sleeves versus polyurethane-coated stents. J. Am. Coll. Cardiol. 24, 525–531 (1994)

166.

Aggarwal, R.K., Ireland, D.C., Azrin, M.A., et al.: Antithrombotic potential of polymer-coated stents eluting platelet glycoprotein IIb/IIIa receptor antibody. Circulation 94, 3311–3317 (1996)

167.

Boland, J.L., Corbeij, H.A., Van Der Giessen, W., et al.: Multicenter evaluation of the phosphorylcholine-coated biodivYsio stent in short de novo coronary lesions: The SOPHOS study. Int. J. Cardiovasc. Interv. 3, 215–225 (2000). doi:10.1080/14628840050515966

168.

Asahara, T., Murohara, T., Sullivan, A., et al.: Isolation of putative progenitor endothelial cells for angiogenesis. Science 275, 964–966 (1997). doi:10.1126/science.275.5302.964

169.

Hristov, M., Erl, W., Weber, P.C.: Endothelial progenitor cells. Arterioscler. Thromb. Vasc. Biol. 23, 1185–1189 (2003). doi:10.1161/01.ATV.0000073832.49290.B5

170.

Peichev, M., Naiyer, A.J., Pereira, D., et al.: Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors. Blood 95, 952–958 (2000)

171.

Aoki, J., Serruys, P.W., van Beusekom, H., et al.: Endothelial progenitor cell capture by stents coated with antibody against CD34: The HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry. J. Am. Coll. Cardiol. 45, 1574–1579 (2005). doi:10.1016/j.jacc.2005.01.048

172.

Duckers, H.J., Silber, S., de Winter, R., et al.: Circulating endothelial progenitor cells predict angiographic and intravascular ultrasound outcome following percutaneous coronary interventions in the HEALING-II trial: evaluation of an endothelial progenitor cell capturing stent. EuroIntervention J. Eur. Collab. Work Group Interv. Cardiol. Eur. Soc. Cardiol. 3, 67–75 (2007)

173.

Duckers, H.J., Soullié, T., den Heijer, P., et al.: Accelerated vascular repair following percutaneous coronary intervention by capture of endothelial progenitor cells promotes regression of neointimal growth at long term follow-up: final results of the Healing II trial using an endothelial progenitor cell capturing stent (Genous R stent). EuroIntervention J. Eur. Collab. Work Group Interv. Cardiol. Eur. Soc. Cardiol. 3, 350–358 (2007)

174.

Bystroň, M., Cervinka, P., Spaček, R., et al.: Randomized comparison of endothelial progenitor cells capture stent versus cobalt-chromium stent for treatment of ST-elevation myocardial infarction. six-month clinical, angiographic, and IVUS follow-up. Catheter. Cardiovasc. Interv. Off. J. Soc. Card. Angiogr. Interv. 76, 627–631 (2010). doi:10.1002/ccd.22612

175.

Beijk, M.A.M., Klomp, M., Verouden, N.J.W., et al.: Genous™ endothelial progenitor cell capturing stent vs. the Taxus Liberté stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study. Eur. Heart J. 31(9), 1055–1064 (2009). doi:10.1093/eurheartj/ehp476

176.

Beijk, M.A.M., Klomp, M., van Geloven, N., et al.: Two-year follow-up of the Genous™ endothelial progenitor cell capturing stent versus the Taxus Liberté stent in patients with de novo coronary artery lesions with a high-risk of restenosis: a randomized, single-center, pilot study. Catheter Cardiovasc. Interv. Off. J. Soc. Card. Angiogr. Interv. 78, 189–195 (2011). doi:10.1002/ccd.23143

177.

Klomp, M., Beijk, M.A., Varma, C., et al.: 1-year outcome of TRIAS HR (TRI-stent adjudication study-high risk of restenosis) a multicenter, randomized trial comparing genous endothelial progenitor cell capturing stents with drug-eluting stents. JACC Cardiovasc. Interv. 4, 896–904 (2011). doi:10.1016/j.jcin.2011.05.011

178.

Markway, B.D., McCarty, O.J.T., Marzec, U.M., et al.: Capture of flowing endothelial cells using surface-immobilized anti-kinase insert domain receptor antibody. Tissue Eng. Part C Methods 14, 97–105 (2008). doi:10.1089/ten.tec.2007.0300

179.

Hoffmann, J., Paul, A., Harwardt, M., et al.: Immobilized DNA aptamers used as potent attractors for porcine endothelial precursor cells. J. Biomed. Mater. Res. A 84, 614–621 (2008). doi:10.1002/jbm.a.31309

180.

Xue, L., Greisler, H.P.: Biomaterials in the development and future of vascular grafts. J. Vasc. Surg. 37, 472–480 (2003). doi:10.1067/mva.2003.88

181.

Hubbell, J.A., Massia, S.P., Desai, N.P., Drumheller, P.D.: Endothelial cell-selective materials for tissue engineering in the vascular graft via a new receptor. Biotechnol. Nat. Publ. Co. 9, 568–572 (1991)

182.

Ochsenhirt, S.E., Kokkoli, E., McCarthy, J.B., Tirrell, M.: Effect of RGD secondary structure and the synergy site PHSRN on cell adhesion, spreading and specific integrin engagement. Biomaterials 27, 3863–3874 (2006). doi:10.1016/j.biomaterials.2005.12.012

183.

Pierschbacher, M., Hayman, E.G., Ruoslahti, E.: Synthetic peptide with cell attachment activity of fibronectin. Proc. Natl. Acad. Sci. USA 80, 1224–1227 (1983)

184.

Tashiro, K., Sephel, G.C., Weeks, B., et al.: A synthetic peptide containing the IKVAV sequence from the A chain of laminin mediates cell attachment, migration, and neurite outgrowth. J. Biol. Chem. 264, 16174–16182 (1989)

185.

Weber, L.M., Hayda, K.N., Haskins, K., Anseth, K.S.: The effects of cell-matrix interactions on encapsulated beta-cell function within hydrogels functionalized with matrix-derived adhesive peptides. Biomaterials 28, 3004–3011 (2007). doi:10.1016/j.biomaterials.2007.03.005

186.

De Mel, A., Jell, G., Stevens, M.M., Seifalian, A.M.: Biofunctionalization of biomaterials for accelerated in situ endothelialization: a review. Biomacromolecules 9, 2969–2979 (2008). doi:10.1021/bm800681k

187.

Veleva, A.N., Heath, D.E., Cooper, S.L., Patterson, C.: Selective endothelial cell attachment to peptide-modified terpolymers. Biomaterials 29, 3656–3661 (2008). doi:10.1016/j.biomaterials.2008.05.022

188.

Schwartz, S.M., Haudenschild, C.C., Eddy, E.M.: Endothelial regneration. I. Quantitative analysis of initial stages of endothelial regeneration in rat aortic intima. Lab. Investig. J. Tech. Methods Pathol. 38, 568–580 (1978)

189.

Schwartz, S.M., Stemerman, M.B., Benditt, E.P.: The aortic intima. II. Repair of the aortic lining after mechanical denudation. Am. J. Pathol. 81, 15–42 (1975)

190.

Haudenschild, C.C., Schwartz, S.M.: Endothelial regeneration. II. Restitution of endothelial continuity. Lab. Investig. J. Tech. Methods Pathol. 41, 407–418 (1979)

191.

Tada, T., Reidy, M.A.: Endothelial regeneration. IX. Arterial injury followed by rapid endothelial repair induces smooth-muscle-cell proliferation but not intimal thickening. Am. J. Pathol. 129, 429–433 (1987)

192.

Doornekamp, F.N., Borst, C., Post, M.J.: The influence of lesion length on intimal hyperplasia after Fogarty balloon injury in the rabbit carotid artery: role of endothelium. J. Vasc. Res. 34, 260–266 (1997)

193.

Busch, R., Strohbach, A., Rethfeldt, S., et al.: New stent surface materials: the impact of polymer-dependent interactions of human endothelial cells, smooth muscle cells, and platelets. Acta Biomater. 10, 688–700 (2014). doi:10.1016/j.actbio.2013.10.015

194.

Busch AS, R.: Parameters of endothelial function are dependent on polymeric surface material. Biomed. Tech. (Berl) (2013). doi:10.1515/bmt-2013-4053

195.

Chaabane, C., Otsuka, F., Virmani, R., Bochaton-Piallat, M.-L.: Biological responses in stented arteries. Cardiovasc. Res. 99, 353–363 (2013). doi:10.1093/cvr/cvt115

196.

Rinder, H.M., Bonan, J.L., Rinder, C.S., et al.: Dynamics of leukocyte-platelet adhesion in whole blood. Blood 78, 1730–1737 (1991)

197.

Anderson, J.M., Rodriguez, A., Chang, D.T.: Foreign body reaction to biomaterials. Semin. Immunol. 20, 86–100 (2008). doi:10.1016/j.smim.2007.11.004

198.

Tengvall, P., Lundström, I., Liedberg, B.: Protein adsorption studies on model organic surfaces: an ellipsometric and infrared spectroscopic approach. Biomaterials 19, 407–422 (1998)

199.

Cohen, H.C., Joyce, E.J., Kao, W.J.: Biomaterials selectively modulate interactions between human blood-derived polymorphonuclear leukocytes and monocytes. Am. J. Pathol. 182, 2180–2190 (2013). doi:10.1016/j.ajpath.2013.02.022

200.

Khandwekar, A.P., Patil, D.P., Shouche, Y., Doble, M.: Surface engineering of polycaprolactone by biomacromolecules and their blood compatibility. J. Biomater. Appl. 26, 227–252 (2011). doi:10.1177/0885328210367442

201.

Henkelman, S., Rakhorst, G., Blanton, J., van Oeveren, W.: Standardization of incubation conditions for hemolysis testing of biomaterials. Mater. Sci. Eng. C 29, 1650–1654 (2009). doi:10.1016/j.msec.2009.01.002

202.

Ratner, B.D.: Blood compatibility—a perspective. J. Biomater. Sci. Polym. Ed. 11, 1107–1119 (2000)

203.

Xu, H., Nguyen, K.T., Brilakis, E.S., et al.: Enhanced endothelialization of a new stent polymer through surface enhancement and incorporation of growth factor-delivering microparticles. J. Cardiovasc. Transl. Res. 5, 519–527 (2012). doi:10.1007/s12265-012-9381-8

204.

Mao, L., Shen, L., Niu, J., et al.: Nanophasic biodegradation enhances the durability and biocompatibility of magnesium alloys for the next-generation vascular stents. Nanoscale 5, 9517–9522 (2013). doi:10.1039/c3nr02912c

205.

Sgarioto, M., Adhikari, R., Gunatillake, P.A., et al.: Properties and in vitro evaluation of high modulus biodegradable polyurethanes for applications in cardiovascular stents. J. Biomed. Mater. Res. B Appl. Biomater. (2014). doi:10.1002/jbm.b.33137

206.

Mukai, Y., Wang, C.-Y., Rikitake, Y., Liao, J.K.: Phosphatidylinositol 3-kinase/protein kinase Akt negatively regulates plasminogen activator inhibitor type 1 expression in vascular endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 292, H1937–H1942 (2007). doi:10.1152/ajpheart.00868.2006

207.

Partridge, J., Carlsen, H., Enesa, K., et al.: Laminar shear stress acts as a switch to regulate divergent functions of NF-kappaB in endothelial cells. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 21, 3553–3561 (2007). doi:10.1096/fj.06-8059com

208.

Ling, X., Ye, J.-F., Zheng, X.-X.: Dynamic investigation of leukocyte-endothelial cell adhesion interaction under fluid shear stress in vitro. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao Acta Biochim. Biophys. Sin. 35, 567–572 (2003)

209.

Taite, L.J., Rowland, M.L., Ruffino, K.A., et al.: Bioactive hydrogel substrates: probing leukocyte receptor-ligand interactions in parallel plate flow chamber studies. Ann. Biomed. Eng. 34, 1705–1711 (2006). doi:10.1007/s10439-006-9173-x

210.

Dunkern, T.R., Paulitschke, M., Meyer, R., et al.: A novel perfusion system for the endothelialisation of PTFE grafts under defined flow. Eur. J. Vasc. Endovasc. Surg. Off. J. Eur. Soc. Vasc. Surg. 18, 105–110 (1999). doi:10.1053/ejvs.1999.0829

211.

Rademacher, A., Paulitschke, M., Meyer, R., Hetzer, R.: Endothelialization of PTFE vascular grafts under flow induces significant cell changes. Int. J. Artif. Organs 24, 235–242 (2001)

212.

Neubert, A., Sternberg, K., Nagel, S., et al.: Development of a vessel-simulating flow-through cell method for the in vitro evaluation of release and distribution from drug-eluting stents. J. Control. Release Off. J. Control. Release Soc. 130, 2–8 (2008). doi:10.1016/j.jconrel.2008.05.012

213.

Seidlitz, A., Nagel, S., Semmling, B., et al.: Examination of drug release and distribution from drug-eluting stents with a vessel-simulating flow-through cell. Eur. J. Pharm. Biopharm. Off J Arbeitsgemeinschaft Für Pharm Verfahrenstechnik EV 78, 36–48 (2011). doi:10.1016/j.ejpb.2010.12.021

214.

Rudolph, A., Eickner, T., Seidlitz, A., et al.: Investigation of in vitro drug release behaviour of drug-eluting stents using a perfusion culture system. Biomed. Eng. Biomed. Tech. (2013)

215.

Gerszten, R.E., Garcia-Zepeda, E.A., Lim, Y.C., et al.: MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398, 718–723 (1999). doi:10.1038/19546

216.

Welt, F.G.P., Rogers, C.: Inflammation and restenosis in the stent era. Arterioscler. Thromb. Vasc. Biol. 22, 1769–1776 (2002)

217.

Hezi-Yamit, A., Sullivan, C., Wong, J., et al.: Impact of polymer hydrophilicity on biocompatibility: implication for DES polymer design. J. Biomed. Mater. Res. A 90, 133–141 (2009). doi:10.1002/jbm.a.32057

218.

Curcio, A., Torella, D., Indolfi, C.: Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting: approach to therapy. Circ. J. Off. J. Jpn. Circ. Soc. 75, 1287–1296 (2011)

219.

Achneck, H.E., Sileshi, B., Parikh, A., et al.: Pathophysiology of bleeding and clotting in the cardiac surgery patient from vascular endothelium to circulatory assist device surface. Circulation 122, 2068–2077 (2010). doi:10.1161/CIRCULATIONAHA.110.936773

220.

Van Kooten, T.G., Klein, C.L., Köhler, H., et al.: From cytotoxicity to biocompatibility testing in vitro: cell adhesion molecule expression defines a new set of parameters. J. Mater. Sci. Mater. Med. 8, 835–841 (1997)

221.

Williams, D.F.: On the mechanisms of biocompatibility. Biomaterials 29, 2941–2953 (2008). doi:10.1016/j.biomaterials.2008.04.023

222.

O’Connor, R.S., Hao, X., Shen, K., et al.: Substrate rigidity regulates human T cell activation and proliferation. J. Immunol. Baltim. Md. 1950 189, 1330–1339 (2012). doi:10.4049/jimmunol.1102757

223.

Gouverneur, M., Berg, B., Nieuwdorp, M., et al.: Vasculoprotective properties of the endothelial glycocalyx: effects of fluid shear stress. J. Intern. Med. 259, 393–400 (2006). doi:10.1111/j.1365-2796.2006.01625.x

224.

Kulangara, K., Leong, K.W.: Substrate topography shapes cell function. Soft Matter 5, 4072–4076 (2009). doi:10.1039/B910132M

225.

Lim, J.Y., Donahue, H.J.: Cell sensing and response to micro- and nanostructured surfaces produced by chemical and topographic patterning. Tissue Eng. 13, 1879–1891 (2007). doi:10.1089/ten.2006.0154

226.

Peterbauer, T., Yakunin, S., Siegel, J., et al.: Dynamics of spreading and alignment of cells cultured in vitro on a grooved polymer surface. J. Nanomater. 2011, e413079 (2010). doi:10.1155/2011/413079

227.

Takai, E., Costa, K.D., Shaheen, A., et al.: Osteoblast elastic modulus measured by atomic force microscopy is substrate dependent. Ann. Biomed. Eng. 33, 963–971 (2005)

228.

Simon, A., Cohen-Bouhacina, T., Porté, M.C., et al.: Characterization of dynamic cellular adhesion of osteoblasts using atomic force microscopy. Cytom. Part J. Int. Soc. Anal. Cytol. 54, 36–47 (2003). doi:10.1002/cyto.a.10052

229.

Kempe, D.S., Lang, P.A., Eisele, K., et al.: Stimulation of erythrocyte phosphatidylserine exposure by lead ions. Am. J. Physiol. Cell Physiol. 288, C396–C402 (2005). doi:10.1152/ajpcell.00115.2004

230.

Dillingham, E.O., Webb, N., Lawrence, W.H., Autian, J.: Biological evaluation of polymers. I. Poly(methyl methacylate). J. Biomed. Mater. Res. 9, 569–596 (1975). doi:10.1002/jbm.820090605

231.

F04 Committee: Practice for assessment of hemolytic properties of materials. ASTM International (2013)

232.

Fischer, D., Li, Y., Ahlemeyer, B., et al.: In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials 24, 1121–1131 (2003). doi:10.1016/S0142-9612(02)00445-3

233.

Parnham, M.J., Wetzig, H.: Toxicity screening of liposomes. Chem. Phys. Lipids 64, 263–274 (1993)

234.

Anderson, N.L., Anderson, N.G.: The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics MCP 1, 845–867 (2002)

235.

Turbill, P., Beugeling, T., Poot, A.A.: Proteins involved in the Vroman effect during exposure of human blood plasma to glass and polyethylene. Biomaterials 17, 1279–1287 (1996)

236.

Hlady, V., Buijs, J., Jennissen, H.P.: Methods for studying protein adsorption. Methods Enzymol. 309, 402–429 (1999)

237.

Tsai, W.-B., Grunkemeier, J.M., McFarland, C.D., Horbett, T.A.: Platelet adhesion to polystyrene-based surfaces preadsorbed with plasmas selectively depleted in fibrinogen, fibronectin, vitronectin, or von Willebrand’s factor. J. Biomed. Mater. Res. 60, 348–359 (2002)

238.

Born, G.V.R.: Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194, 927–929 (1962). doi:10.1038/194927b0

239.

Goldman, A.J., Cox, R.G., Brenner, H.: Slow viscous motion of a sphere parallel to a plane wall—II Couette flow. Chem. Eng. Sci. 22, 653–660 (1967). doi:10.1016/0009-2509(67)80048-4

240.

Lawrence, M.B.: In vitro flow models of leukocyte adhesion. In: Ley, K. (ed) Physiology of Inflammation, pp. 204–221. Springer, New York (2001)

241.

Chang, X., Gorbet, M.: The effect of shear on in vitro platelet and leukocyte material-induced activation. J. Biomater. Appl. 28, 407–415 (2013). doi:10.1177/0885328212454689

242.

Sirolli, V., Ballone, E., Amoroso, L., et al.: Leukocyte adhesion molecules and leukocyte-platelet interactions during hemodialysis: effects of different synthetic membranes. Int. J. Artif. Organs 22, 536–542 (1999)

243.

Uurto, I., Juuti, H., Parkkinen, J., et al.: Biodegradable self-expanding poly-l/d-lactic acid vascular stent: a pilot study in canine and porcine iliac arteries. J. Endovasc. Ther. Off. J. Int. Soc. Endovasc. Spec. 11, 712–718 (2004). doi:10.1583/04-127MR.1

244.

Venkatraman, S.S., Tan, L.P., Joso, J.F.D., et al.: Biodegradable stents with elastic memory. Biomaterials 27, 1573–1578 (2006). doi:10.1016/j.biomaterials.2005.09.002

245.

Venkatraman, S., Poh, T.L., Vinalia, T., et al.: Collapse pressures of biodegradable stents. Biomaterials 24, 2105–2111 (2003)

246.

Zilberman, M., Nelson, K.D., Eberhart, R.C.: Mechanical properties and in vitro degradation of bioresorbable fibers and expandable fiber-based stents. J. Biomed. Mater. Res. B Appl. Biomater. 74, 792–799 (2005). doi:10.1002/jbm.b.30319

247.

Welch, T.R., Eberhart, R.C., Chuong, C.-J.: The influence of thermal treatment on the mechanical characteristics of a PLLA coiled stent. J. Biomed. Mater. Res. B Appl. Biomater. 90, 302–311 (2009). doi:10.1002/jbm.b.31286

248.

Grabow, N., Bünger, C.M., Schultze, C., et al.: A biodegradable slotted tube stent based on poly(l-lactide) and poly(4-hydroxybutyrate) for rapid balloon-expansion. Ann. Biomed. Eng. 35, 2031–2038 (2007). doi:10.1007/s10439-007-9376-9

249.

Grabow, N., Bünger, C.M., Sternberg, K., et al.: Mechanical properties of a biodegradable balloon-expandable stent from poly(l-lactide) for peripheral vascular applications. J. Med. Devices 1, 84–88 (2006). doi:10.1115/1.2355683

250.

Grabow, N., Schlun, M., Sternberg, K., et al.: Mechanical properties of laser cut poly(l-lactide) micro-specimens: implications for stent design, manufacture, and sterilization. J. Biomech. Eng. 127, 25–31 (2005)

251.

Bünger, C.M., Grabow, N., Sternberg, K., et al.: Sirolimus-eluting biodegradable poly-L-lactide stent for peripheral vascular application: a preliminary study in porcine carotid arteries. J. Surg. Res. 139, 77–82 (2007). doi:10.1016/j.jss.2006.07.035

252.

Petersen, S., Hussner, J., Reske, T., et al.: In vitro study of dual drug-eluting stents with locally focused sirolimus and atorvastatin release. J. Mater. Sci. Mater. Med. 24, 2589–2600 (2013). doi:10.1007/s10856-013-5001-7

253.

Nugroho, P., Mitomo, H., Yoshii, F., Kume, T.: Degradation of poly(l-lactic acid) by γ-irradiation. Polym. Degrad. Stab. 72, 337–343 (2001). doi:10.1016/S0141-3910(01)00030-1

254.

Nuutinen, J.-P., Välimaa, T., Clerc, C., Törmälä, P.: Mechanical properties and in vitro degradation of bioresorbable knitted stents. J. Biomater. Sci. Polym. Ed. 13, 1313–1323 (2002). doi:10.1163/15685620260449714

255.

Pistner, H.: Osteosynthese mit bioresorbierbaren Materialien: Entwicklung einer Schraube vom Werkstoff bis zur klinischen Anwendung, Einhorn-Presse-Verlag (1999)

256.

Sharon Xin, Lu, Cebe, P.: Effects of annealing on the disappearance and creation of constrained amorphous phase. Polymer 37, 4857–4863 (1996). doi:10.1016/S0032-3861(96)00376-X

257.

Delpouve, N., Saiter, A., Mano, J.F., Dargent, E.: Cooperative rearranging region size in semi-crystalline poly(l-lactic acid). Polymer 49, 3130–3135 (2008). doi:10.1016/j.polymer.2008.04.045

258.

Kelsch, B., Scheller, B., Biedermann, M., et al.: Dose response to Paclitaxel-coated balloon catheters in the porcine coronary overstretch and stent implantation model. Invest. Radiol. 46, 255–263 (2011). doi:10.1097/RLI.0b013e31820577df

259.

Kallmes, D.F., McGraw, J.K., Evans, A.J., et al.: Thrombogenicity of hydrophilic and nonhydrophilic microcatheters and guiding catheters. AJNR Am. J. Neuroradiol. 18, 1243–1251 (1997)

260.

Nagaoka, S., Akashi, R.: Low-friction hydrophilic surface for medical devices. Biomaterials 11, 419–424 (1990)

Title: Polymers in Cardiology
Authors: Katrin Sternberg
Raila Busch
Svea Petersen
Publisher: Springer International Publishing
Book: Advanced Polymers in Medicine
Print ISBN: 978-3-319-12477-3

Electronic ISBN: 978-3-319-12478-0

Copyright Year: 2015
DOI: https://doi.org/10.1007/978-3-319-12478-0_15

Springer Professional

Abstract

Please log in to get access to your license.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Springer Professional "Technik"

Premium Partners